Two men, seated indoors around a table, engaged in a conversation and playing chess

Discover our medicines

Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
A female research scientist in a lab looking at a sample

Explore our science

Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
Group of warm clothed women, seated outside, smiling and laughing

Learn about our impact

Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.

Latest news

Jul 08, 2025

  • Press release

Novartis receives approval for first malaria medicine for newborn babies and young infants

Jul 03, 2025

  • Press release

Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)

Jun 25, 2025

  • Press release

Novartis completes acquisition of Regulus Therapeutics
All news
High resolution picture of an artificial heart muscle from a research lab in Cambridge.

Live. Magazine

Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.

Learn more
Three business people laughing

Welcome to where we thrive together

Working together. Learning together. Thriving together. Discover how you can join us in changing people's lives.
Join us
Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Novartis in Society Integrated Report 2024

Read more about our performance against our business, environmental, social and governance (ESG) priorities in the Novartis in Society Integrated Report 2024.

Download the Integrated Report (PDF 5.0 MB)

Resource links

About Novartis
Healthcare professionals
Patients and caregivers
Pipeline
Products